Skip to main content

Find Clinical Trials

Home
Conditions
Severe Combined Immunodeficiency Due to ADA Deficiency

Clinical trial condition

Severe Combined Immunodeficiency Due to ADA Deficiency

Explore clinical trials studying Severe Combined Immunodeficiency Due to ADA Deficiency. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Severe Combined Immunodeficiency Due to ADA Deficiency trial results

Completed

Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)

NCT03232203

Conditions: Severe Combined Immunodeficiency Due to ADA Deficiency, Severe combined immunodeficiency due to adenosine deaminase deficiency
Locations: Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR-TIGET) Milan, Italy

View Trial Details

Completed

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

NCT03765632

Conditions: Severe Combined Immunodeficiency Due to ADA Deficiency, Severe combined immunodeficiency due to adenosine deaminase deficiency
Locations: Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

NCT02999984

Conditions: Severe Combined Immunodeficiency Due to ADA Deficiency, Severe combined immunodeficiency due to adenosine deaminase deficiency
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Severe combined immunodeficiency due to adenosine deaminase deficiency (3)